| 000 | 01715 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515075505.0 | ||
| 264 | 0 | _c20080619 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s00280-007-0560-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoghaert, Erwin R | |
| 245 | 0 | 0 |
_aDetermination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 microl) blood samples. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cMay 2008 |
||
| 300 |
_a1027-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAminoglycosides _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aGemtuzumab |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInotuzumab Ozogamicin |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSurface Plasmon Resonance |
| 700 | 1 | _aKhandke, Kiran M | |
| 700 | 1 | _aSridharan, Latha | |
| 700 | 1 | _aDougher, Maureen | |
| 700 | 1 | _aDiJoseph, John F | |
| 700 | 1 | _aKunz, Arthur | |
| 700 | 1 | _aHamann, Philip R | |
| 700 | 1 | _aMoran, Justin | |
| 700 | 1 | _aChaudhary, Inder | |
| 700 | 1 | _aDamle, Nitin K | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 61 _gno. 6 _gp. 1027-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-007-0560-2 _zAvailable from publisher's website |
| 999 |
_c17201048 _d17201048 |
||